Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Notes Payable (Details Textual)

v3.8.0.1
Note 10 - Notes Payable (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Mar. 03, 2017
Jun. 22, 2016
Dec. 31, 2016
Sep. 30, 2017
Sep. 30, 2016
Mar. 31, 2016
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Feb. 28, 2017
May 31, 2015
Jul. 31, 2012
Paid-in-Kind Interest               $ 211,443 $ 1,367,259      
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)                 (1,800,000)      
Interest Expense, Debt       $ 26,000 $ 2,600,000     1,800,000 12,300,000      
Amortization of Debt Discount (Premium)       29,000 190,000     0 78,000      
Term Loan Agreement [Member] | Cardinal Health 414 [Member]                        
Letters of Credit Outstanding, Amount $ 7,000,000                      
Term Loan Agreement [Member] | CRG [Member]                        
Letters of Credit Outstanding, Amount 12,000,000                      
Notes Payable Issued for Prepayment of Insurance Premiums [Member] | IPFS [Member]                        
Notes Payable     $ 306,000 0       0        
Debt Instrument, Face Amount     $ 348,000                  
Debt Instrument, Interest Rate, Stated Percentage     8.99%                  
Debt Instrument, Term     240 days                  
Debt Instrument, Periodic Payment     $ 45,000                  
Capital Royalty Group, Term Loan [Member]                        
Payments to Collection of Collateral on Claims of Default             $ 778,000   778,000      
Payments to Prepayment Premium on Claims of Default             2,100,000   2,100,000      
Debt Instrument, Unamortized Discount         2,000,000   $ 2,000,000   2,000,000      
PPCO [Member] | Platinum Loan Agreement [Member]                        
Line of Credit Facility, Maximum Borrowing Capacity                       $ 50,000,000
Repayments of Debt 7,700,000                      
Convertible Debt 1,900,000                      
Paid-in-Kind Interest               211,000 814,000      
Notes Payable     9,487,822 1,981,676       1,981,676        
Embedded Derivative, Fair Value of Embedded Derivative Liability     153,000 0       0        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)       $ 0 $ 839,000     $ (153,000) $ (1,800,000)      
CRG [Member] | Term Loan Agreement [Member]                        
Repayments of Debt 59,000,000                      
Paid-in-Kind Interest           $ 519,000            
Notes Payable     51,700,000                  
Debt Instrument, Face Amount                     $ 50,000,000  
Debt Instrument, Additional Loans That May Be Made Available Upon the Satisfaction of Certain Conditions                     $ 10,000,000  
Primary Bank Account Cash Taken Possession Of By Creditor   $ 4,100,000                    
Debt Instrument, Final Payoff Amount, Threshold Above Which the Reporting Entity Will First Pay Without Resorting to Letter of Credit 59,000,000                      
Debt Instrument, Interest Rate, Stated Percentage                   14.00%    
CRG [Member] | Term Loan Agreement [Member] | Minimum [Member]                        
Debt Instrument, Agreed-upon Final Payoff Amount 47,000,000                      
CRG [Member] | Term Loan Agreement [Member] | Maximum [Member]                        
Debt Instrument, Agreed-upon Final Payoff Amount $ 66,000,000                      
CRG [Member] | Term Loan Agreement [Member] | Accrued Liabilities and Other [Member]                        
Interest Payable, Current     $ 5,800,000